CRI CEO and Director of Scientific Affairs Dr. Jill O’Donnell-Tormey on Immunotherapy and Her Tenure NEW YORK – Jill O’Donnell-Tormey, PhD, CEO and director of scientific affairs at the Cancer Research Institute... December 21, 2023December 21, 2023
Cancer Research Institute Joins Lance Kawaguchi, #SouthPoleTrek4Cancer to Ring the Nasdaq Stock Market Closing Bell Contact: Melinda Koski, SouthPoleTrek4Cancer Sharon Slade, Chief Marketing Officer, CRI For Immediate Release Tuesday, December 19, 2023... December 19, 2023December 19, 2023
The Cancer Research Institute’s Patient Immunotherapy Summit is Now Available On Demand NEW YORK — The Cancer Research Institute (CRI) is excited to announce the premiere of the seventh... December 6, 2023December 6, 2023
CRI CEO Dr. Jill O’Donnell-Tormey on How Data Drives Immunotherapy Advances New York, November 22, 2023 Recently, the Cancer Research Institute’s (CRI) CEO and Director of Scientific Affairs... November 22, 2023November 22, 2023
Cancer Research Institute to Honor Dr. Ananda Goldrath with 2023 Alt Award New York, October 27, 2023 The Cancer Research Institute (CRI), a nonprofit organization dedicated to harnessing the... October 27, 2023November 22, 2023
Israel Cancer Research Fund and Cancer Research Institute Announce Co-Funding of a Project Grant October 11, 2023